+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 50 Pages
  • Global
From
Global Hyperkalemia Drugs Market 2022-2026 - Product Thumbnail Image

Global Hyperkalemia Drugs Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
Hyperkalemia Treatment Market - Growth, Trends, and Forecasts (2023-2028) - Product Thumbnail Image

Hyperkalemia Treatment Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 354 Pages
  • Global
From
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 126 Pages
  • Global
From
Hyperkalemia Market: A Research Perspective - Product Thumbnail Image

Hyperkalemia Market: A Research Perspective

  • Report
  • February 2020
  • 19 Pages
  • Global
From
Top Selling Biologics Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis, Other Life Cycle Management Strategies, Competition from Biosimilars, Annual Treatment Cost Comparison, Sales Evolution and Future Opportunity - Product Thumbnail Image

Top Selling Biologics Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis, Other Life Cycle Management Strategies, Competition from Biosimilars, Annual Treatment Cost Comparison, Sales Evolution and Future Opportunity

  • Report
  • April 2021
  • 242 Pages
  • Global
From
Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Iron Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 187 Pages
  • Global
From
Intravenous Iron Drugs Market Size, Share & Trends Analysis Report By Product (Iron Sucrose, Iron Dextran, Ferric Carboxymaltose), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Intravenous Iron Drugs Market Size, Share & Trends Analysis Report By Product (Iron Sucrose, Iron Dextran, Ferric Carboxymaltose), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • May 2023
  • 100 Pages
  • Global
From
Hyperkalemia - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hyperkalemia - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Global Intravenous Iron Drugs Market by Product (Ferric Carboxymaltose, Iron Dextran, Iron Sucrose), Application (Cancer, Chronic Kidney Disease, Inflammatory Bowel Disease) - Forecast 2024-2030 - Product Thumbnail Image

Global Intravenous Iron Drugs Market by Product (Ferric Carboxymaltose, Iron Dextran, Iron Sucrose), Application (Cancer, Chronic Kidney Disease, Inflammatory Bowel Disease) - Forecast 2024-2030

  • Report
  • March 2024
  • 187 Pages
  • Global
From
IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026 - Product Thumbnail Image

IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026

  • Report
  • February 2021
  • 342 Pages
  • Global
From
Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Global Drug Forecast and Market Analysis to 2030

  • Report
  • April 2021
  • 122 Pages
  • Global
From
Global Iron Drugs Market 2023-2027 - Product Thumbnail Image

Global Iron Drugs Market 2023-2027

  • Report
  • May 2023
  • 159 Pages
  • Global
From
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 51 Pages
  • Global
From
Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Application (Intestinal malabsorption syndromes, Inflammatory diseases, Others), By Product, By End-User, By Company, By Region, Forecast & Opportunities, 2028 - Product Thumbnail Image

Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Application (Intestinal malabsorption syndromes, Inflammatory diseases, Others), By Product, By End-User, By Company, By Region, Forecast & Opportunities, 2028

  • Report
  • December 2022
  • 118 Pages
  • Global
From
Nephrology Drugs Global Market Report 2024 - Product Thumbnail Image

Nephrology Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Intravenous Iron Drugs Market - Growth, Trends, and Forecasts (2023-2028) - Product Thumbnail Image

Intravenous Iron Drugs Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Global Hyperphosphatemia Drugs Market Report by Product, Dosage Form, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Global Hyperphosphatemia Drugs Market Report by Product, Dosage Form, Distribution Channel, and Region 2024-2032

  • Report
  • April 2024
  • 137 Pages
  • Global
From
Hyperphosphatemia Treatment Global Market Report 2024 - Product Thumbnail Image

Hyperphosphatemia Treatment Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Loading Indicator